Literature DB >> 22644486

Metformin interacts with AMPK through binding to γ subunit.

Yaya Zhang1, Yongjun Wang, Chuanen Bao, Yingyi Xu, Huili Shen, Junjie Chen, Jianghua Yan, Yuqiang Chen.   

Abstract

Metformin acts as an energy regulator by activating 5'-adenosine monophosphate-activated protein kinase (AMPK), which is a key player in the regulation of energy homeostasis, but it is uncertain whether AMPK is its direct target. This study aims to investigate the possible interaction between metformin and AMPK. First, we verified that metformin can promote AMPK activation and induce ACC inactivation in human HepG2 cells using western blot. Then we predicted that metformin may interact with the γ subunit of AMPK by molecular docking analysis. The fluorescence spectrum and ForteBio assays indicated that metformin has a stronger binding ability to the γ subunit of AMPK than to α subunit. In addition, interaction of metformin with γ-AMPK resulted in a decrease in the α-helicity determined by CD spectra, but relatively little change was seen with α-AMPK. These results demonstrate that metformin may interact with AMPK through binding to the γ subunit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644486     DOI: 10.1007/s11010-012-1344-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

Review 1.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

Review 2.  Metformin: its emerging role in oncology.

Authors:  Dragan Micic; Goran Cvijovic; Vladimir Trajkovic; Leonidas H Duntas; Snezana Polovina
Journal:  Hormones (Athens)       Date:  2011 Jan-Mar       Impact factor: 2.885

3.  Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

Authors:  X-X He; S M Tu; M-H Lee; S-C J Yeung
Journal:  Ann Oncol       Date:  2011-03-17       Impact factor: 32.976

4.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

5.  Mechanism by which metformin reduces glucose production in type 2 diabetes.

Authors:  R S Hundal; M Krssak; S Dufour; D Laurent; V Lebon; V Chandramouli; S E Inzucchi; W C Schumann; K F Petersen; B R Landau; G I Shulman
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

6.  Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.

Authors:  J M Lenhard; S A Kliewer; M A Paulik; K D Plunket; J M Lehmann; J E Weiel
Journal:  Biochem Pharmacol       Date:  1997-10-01       Impact factor: 5.858

Review 7.  Metformin and cancer: new applications for an old drug.

Authors:  Taxiarchis V Kourelis; Robert D Siegel
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

8.  Mechanism of interaction between human serum albumin and N-alkyl phenothiazines studied using spectroscopic methods.

Authors:  P B Kandagal; S S Kalanur; D H Manjunatha; J Seetharamappa
Journal:  J Pharm Biomed Anal       Date:  2008-01-20       Impact factor: 3.935

9.  Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.

Authors:  H S Hundal; T Ramlal; R Reyes; L A Leiter; A Klip
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

10.  2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase.

Authors:  Qilong Wang; Bin Liang; Najeeb A Shirwany; Ming-Hui Zou
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

View more
  18 in total

1.  AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1.

Authors:  Traci L Marin; Brendan Gongol; Fan Zhang; Marcy Martin; David A Johnson; Han Xiao; Yinsheng Wang; Shankar Subramaniam; Shu Chien; John Y-J Shyy
Journal:  Sci Signal       Date:  2017-01-31       Impact factor: 8.192

2.  The SNF1 Kinase Ubiquitin-associated Domain Restrains Its Activation, Activity, and the Yeast Life Span.

Authors:  Rubin Jiao; Spike Postnikoff; Troy A Harkness; Terra G Arnason
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

Review 3.  Nuclear receptors and AMPK: can exercise mimetics cure diabetes?

Authors:  Christopher E Wall; Ruth T Yu; Anne R Atkins; Michael Downes; Ronald M Evans
Journal:  J Mol Endocrinol       Date:  2016-04-22       Impact factor: 5.098

4.  Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury.

Authors:  Ming-Yuan Jian; Mikhail F Alexeyev; Paul E Wolkowicz; Jaroslaw W Zmijewski; Judy R Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

5.  Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells.

Authors:  Chen Qu; Weijia Zhang; Guopei Zheng; Zijuan Zhang; Jiang Yin; Zhimin He
Journal:  Mol Cell Biochem       Date:  2013-10-06       Impact factor: 3.396

6.  AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.

Authors:  Guifen He; Yi-Wei Zhang; Jun-Ho Lee; Shelya X Zeng; Yunyuan V Wang; Zhijun Luo; X Charlie Dong; Benoit Viollet; Geoffrey M Wahl; Hua Lu
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

7.  Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.

Authors:  Jennifer L Miller; Tiffany D Linville; Elisabeth M Dykens
Journal:  J Pediatr Endocrinol Metab       Date:  2014-01       Impact factor: 1.634

Review 8.  AMPK at the nexus of energetics and aging.

Authors:  Kristopher Burkewitz; Yue Zhang; William B Mair
Journal:  Cell Metab       Date:  2014-04-10       Impact factor: 27.287

9.  Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity.

Authors:  Antje Bruckbauer; Michael B Zemel
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-13       Impact factor: 3.168

10.  Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.

Authors:  Bruna Corominas-Faja; Rosa Quirantes-Piné; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Sílvia Cufí; Begoña Martin-Castillo; Vicente Micol; Jorge Joven; Antonio Segura-Carretero; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2012-07       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.